炎症在良性前列腺增生中的作用。
Role of inflammation in benign prostatic hyperplasia.
作者信息
Chughtai Bilal, Lee Richard, Te Alexis, Kaplan Steven
机构信息
Department of Urology, Weill Cornell Medical College, New York, NY.
出版信息
Rev Urol. 2011;13(3):147-50.
Abstract
Inflammation of the prostate may represent a mechanism for hyperplastic changes to occur in the prostate. There are a variety of growth factors and cytokines that may lead to a proinflammatory process within the prostate. There are several proposed mechanisms that lead to both the intrinsic and extrinsic basis of inflammation. Prostatic inflammation may represent an important factor in influencing prostatic growth and progression of symptoms. This article reviews the recent literature on inflammation leading to chronic prostatic diseases, such as benign prostatic hyperplasia.
摘要
前列腺炎症可能是前列腺发生增生性改变的一种机制。有多种生长因子和细胞因子可能导致前列腺内的促炎过程。有几种提出的机制导致了炎症的内在和外在基础。前列腺炎症可能是影响前列腺生长和症状进展的一个重要因素。本文综述了近期关于导致慢性前列腺疾病（如良性前列腺增生）的炎症的文献。
相似文献
1
Role of inflammation in benign prostatic hyperplasia.炎症在良性前列腺增生中的作用。
Rev Urol. 2011;13(3):147-50.
2
Inflammation and benign prostatic hyperplasia: clinical implications.炎症与良性前列腺增生：临床意义。
Curr Urol Rep. 2011 Aug;12(4):274-7. doi: 10.1007/s11934-011-0191-3.
3
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.慢性前列腺炎与良性前列腺增生的严重程度和进展、下尿路症状以及急性尿潴留风险相关。
J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1.
4
Multidisciplinary approach to prostatitis.前列腺炎的多学科治疗方法。
Arch Ital Urol Androl. 2019 Jan 18;90(4):227-248. doi: 10.4081/aiua.2018.4.227.
5
Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.炎症在汉族男性良性前列腺增生发展中的作用：一项基于人群和单机构的分析。
Int J Urol. 2015 Dec;22(12):1138-42. doi: 10.1111/iju.12914. Epub 2015 Aug 27.
6
Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer?尸检前列腺中前列腺炎的评估——慢性炎症与良性前列腺增生还是癌症的关联更大？
J Urol. 2008 May;179(5):1736-40. doi: 10.1016/j.juro.2008.01.034. Epub 2008 Mar 17.
7
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.慢性炎症在良性前列腺增生发病机制中的作用
Int J Androl. 2010 Jun 1;33(3):475-88. doi: 10.1111/j.1365-2605.2009.00972.x. Epub 2009 Jun 8.
8
[Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
Pol Merkur Lekarski. 2004 Oct;17(100):307-10.
9
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.良性前列腺增生症与前列腺癌之间的争议性关系：炎症的作用。
Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9.
10
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.前列腺疾病中慢性炎症的分子基础及临床后果：前列腺炎、良性前列腺增生和前列腺癌。
Cancers (Basel). 2023 Jun 8;15(12):3110. doi: 10.3390/cancers15123110.
引用本文的文献
1
The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?良性前列腺增生患者感染新型冠状病毒的经历：二者之间是否存在关联？
Maedica (Bucur). 2025 Mar;20(1):112-116. doi: 10.26574/maedica.2025.20.1.112.
2
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia.一项随机、活性药物对照、多中心、3期临床试验，旨在评估GV1001治疗良性前列腺增生患者的疗效和安全性。
Prostate Int. 2025 Jun;13(2):81-89. doi: 10.1016/j.prnil.2024.10.001. Epub 2024 Oct 11.
3
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications.探索良性前列腺增生中的转化生长因子-β信号传导：从细胞衰老到纤维化及其治疗意义
Biogerontology. 2025 Mar 30;26(2):79. doi: 10.1007/s10522-025-10226-x.
4
Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives.良性前列腺增生中的氧化应激：机制、临床相关性及治疗前景
Diseases. 2025 Feb 11;13(2):53. doi: 10.3390/diseases13020053.
5
Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia.胡芦巴提取物对丙酸睾酮诱导的良性前列腺增生的影响。
Int J Mol Sci. 2025 Jan 31;26(3):1261. doi: 10.3390/ijms26031261.
6
The Impact of Body Mass Index and Benign Prostatic Hyperplasia on Bone Health of Middle-Aged and Older Men.体重指数和良性前列腺增生对中老年男性骨骼健康的影响。
Obes Sci Pract. 2025 Jan 8;11(1):e70037. doi: 10.1002/osp4.70037. eCollection 2025 Feb.
7
Lc-ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia.基于液相色谱-质谱联用的非靶向代谢组学揭示了组织学慢性炎症促进前列腺增生的潜在机制。
PLoS One. 2024 Dec 23;19(12):e0314599. doi: 10.1371/journal.pone.0314599. eCollection 2024.
8
Fucoidan Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Rats.岩藻依聚糖改善大鼠睾酮诱导的良性前列腺增生（BPH）。
Res Rep Urol. 2024 Oct 30;16:283-297. doi: 10.2147/RRU.S478740. eCollection 2024.
9
Autophagy in benign prostatic hyperplasia: insights and therapeutic potential.前列腺增生中的自噬：见解与治疗潜力。
BMC Urol. 2024 Sep 12;24(1):198. doi: 10.1186/s12894-024-01585-7.
10
Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ.齐墩果酸通过激活PPAR-γ减轻睾酮诱导的大鼠良性前列腺增生。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1991-2001. doi: 10.1007/s00210-024-03405-z. Epub 2024 Sep 2.
本文引用的文献
1
A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.对前列腺癌患者一级亲属进行前列腺特异性抗原筛查的流行情况和风险认知的综述。
Eur J Cancer Care (Engl). 2009 Nov;18(6):545-55. doi: 10.1111/j.1365-2354.2008.01046.x.
2
Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.良性前列腺增生中的炎症：282例患者的免疫组织化学分析
Prostate. 2009 Dec 1;69(16):1774-80. doi: 10.1002/pros.21027.
3
The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.维生素D受体激动剂依洛膦酸通过靶向RhoA/Rho激酶和NF-κB途径抑制白细胞介素-8依赖性良性前列腺增生基质细胞增殖和炎症反应。
Prostate. 2009 Apr 1;69(5):480-93. doi: 10.1002/pros.20896.
4
Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study.塞来昔布治疗良性前列腺增生引起的夜尿症：一项前瞻性、随机、双盲、安慰剂对照研究。
Urology. 2008 Oct;72(4):813-6. doi: 10.1016/j.urology.2008.04.069. Epub 2008 Aug 9.
5
BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.良性前列腺增生进展：来自MTOPS、ALTESS、COMBAT和ALF-ONE的概念及关键认识。
BJU Int. 2008 Mar;101 Suppl 3:17-21. doi: 10.1111/j.1464-410X.2008.07497.x.
6
Inflammation and benign prostatic hyperplasia.炎症与良性前列腺增生
Urol Clin North Am. 2008 Feb;35(1):109-15; vii. doi: 10.1016/j.ucl.2007.09.012.
7
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.前列腺炎症状与组织学炎症之间的关系研究：REDUCE化学预防试验的基线数据
J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. doi: 10.1016/j.juro.2007.05.041. Epub 2007 Jul 16.
8
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?前列腺内炎症在良性前列腺增生的发病机制及进展过程中起作用吗？
BJU Int. 2007 Aug;100(2):327-31. doi: 10.1111/j.1464-410X.2007.06910.x.
9
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.维生素D受体激动剂依洛钙化醇对非肥胖糖尿病小鼠实验性自身免疫性前列腺炎的治疗作用
J Immunol. 2006 Dec 15;177(12):8504-11. doi: 10.4049/jimmunol.177.12.8504.
10
BPH: epidemiology and comorbidities.良性前列腺增生：流行病学与共病
Am J Manag Care. 2006 Apr;12(5 Suppl):S122-8.
Zotero 插件